Neurelis, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2007-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.neurelis.com
Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
4
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
A Study of Olanzapine After Intranasal and Intramuscular Administration
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Neurelis, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06600477
- Locations
- 🇯🇴
International Pharmaceutical Research Center (IPRC) Clinical Site, Amman, Jordan
Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy
- First Posted Date
- 2021-10-13
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- Neurelis, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT05076838
- Locations
- 🇺🇸
Northwest Florida Clinical Research Group, LLC., Gulf Breeze, Florida, United States
🇺🇸Nicklaus Children's Hospital, Miami, Florida, United States
🇺🇸AdventHealth Research Institute, Orlando, Florida, United States
Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- Neurelis, Inc.
- Target Recruit Count
- 57
- Registration Number
- NCT02724423
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇺🇸Le Bonheur Children's Hospita, Memphis, Tennessee, United States
Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects
- First Posted Date
- 2016-03-28
- Last Posted Date
- 2022-01-31
- Lead Sponsor
- Neurelis, Inc.
- Target Recruit Count
- 175
- Registration Number
- NCT02721069
- Locations
- 🇺🇸
Clinical Trials, Inc., Little Rock, Arkansas, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States